Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500

NCT02107872 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Disorders

Interventions

DRUG: REGN1500
DRUG: placebo

Sponsor

Regeneron Pharmaceuticals